Cera, Europe’s leading digital-first home healthcare provider, has surpassed 300 billion data points—a milestone set to help transform AI-powered care and global healthcare research for ageing populations.
Delivering more than 2.5 million patient home visits every month, Cera’s frontline teams capture real-world insights into the health and wellbeing of older people in their own homes.
These observations range from symptoms, mobility changes and medication responses to nutrition, hydration, mood and behavioural signals — creating one of the world’s most comprehensive datasets on day-to-day health outside clinical settings.
This rapidly growing dataset is now helping to power the next generation of Cera’s AI technology, while also supporting collaborations with leading organisations across healthcare, research and life sciences.
Dr Ben Maruthappu, founder and CEO of Cera, said: “Reaching 300 billion data points is a key milestone for Cera and for the future of home healthcare.
“Our dataset reflects the real-world health experiences captured through millions of care visits delivered in people’s homes.
“By combining these insights with AI, we can help healthcare professionals act earlier, improve outcomes for patients, and support groundbreaking research into some of the world’s most pressing health challenges.”
Advancing Real-World Healthcare Research
Pharmaceutical and life sciences organisations increasingly rely on real-world evidence to understand how diseases progress and how treatments work outside clinical trials.
Data captured in people’s homes can provide unique insights into how conditions evolve in everyday life.
To support this growing demand, Cera has established partnerships with Akrivia Health, Promptly Health, and Re:Cognition Health.
These collaborations will enable researchers and life sciences organisations to access anonymised, real-world healthcare insights that help accelerate research into conditions including dementia, neurological diseases, and chronic illnesses.
Life Sciences and Pharmaceutical companies increasingly rely on this longitudinal data to support drug development and regulatory approval.
Powering AI for the Future of Home Healthcare
This dataset also powers and continuously improves Cera’s pioneering AI technology, powering its portfolio of AI agents, robotics, and preventative tools.
These include AI systems that support workforce recruitment, care coordination, and clinical documentation, as well as predictive algorithms that identify early warning signs of health deterioration — enabling earlier intervention and helping prevent avoidable hospitalisations.
By analysing patterns across hundreds of billions of real-world care observations, Cera’s AI agents can also help frontline teams work more efficiently, reducing administrative burden and improving workforce productivity while enabling carers and nurses to focus more time on direct patient care.
As the dataset continues to grow, it strengthens the accuracy and capability of these AI systems, enabling more personalised, preventative and efficient care for patients in their own homes.
Maruthappu said: “With our growing research partnerships and continued AI innovation, this milestone strengthens the foundation for the next phase of Cera’s growth — transforming healthcare delivery while supporting the development of new treatments and better care models worldwide.”
